#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatitis D Hormone-dependent prostate cancer Acute leukaemia Dementia Carcinoid tumour Infertility male Alveolar proteinosis Factor VIII deficiency Myelodysplastic syndrome with excess blasts Fontan procedure Hyperphagia Mantle cell lymphoma recurrent Mantle cell lymphoma refractory Erdheim-Chester disease Intracranial germ cell tumour More trials…

    Learn about Rare Diseases

    Alagille syndrome – Basic Information Urea cycle disorder Glomerulonephritis membranous – Basic Information Ehlers-Danlos syndrome Progressive multifocal leukoencephalopathy Pulmonary sarcoidosis – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) – Basic Information Testicular leiomyosarcoma – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Treatment VEXAS syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Oric-114 Clazakizumab Ranolazine Zenocutuzumab Amitriptyline Hydrochloride Natalizumab Dazucorilant Varegacestat TUVATEXIB Rbl016.2 Adezunap Amsacrine Pegaspargase Flutemetamol (18F) Domperidone Aavanc80-5'Hotof Budesonide Timolol Maleate Nelarabine PICLIDENOSON More therapies…

    Learn about Your Condition

    Hyperadrenocorticism Noonan syndrome Parkinson's disease Bladder cancer recurrent Gastrooesophageal cancer Choreoathetosis Myxofibrosarcoma Medulloblastoma recurrent Immune system disorder Huntington's disease Myeloproliferative neoplasm Deafness Somatic symptom disorder Hepatoblastoma Osteosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Immune-mediated myositis

  • Study on Upadacitinib for Patients with Idiopathic Inflammatory Myopathies After Stopping IVIG

    Recruiting

    2 1 1
    Investigated Diseases:
    • Antisynthetase syndrome
    • Necrotising myositis
    • Immune-mediated myositis
    Investigated Drugs:
    • Upadacitinib
    Austria

  • Study on the Effects of Rapcabtagene Autoleucel and Drug Combination for Patients with Severe Refractory Inflammatory Muscle Diseases

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Immune-mediated myositis
    Investigated Drugs:
    • Mycophenolic Acid
    • Fludarabine Phosphate
    • Rapcabtagene Autoleucel
    Austria Belgium Czechia Finland France Germany +7

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!